# Emergent Medical Partners

> Emergent Medical Partners is a VC fund backing Health Care and Medical Device. See 39 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Portola Valley, United States
- Total investments: 39
- Last investment: Mar 2024
- Lead investor: 10%
- Last fund: Sep 2013
- Last updated: Aug 2026
- Website: http://www.emvllp.com

Emergent Medical Partners is a California-based life sciences investment firm focused on medical device and healthcare companies. The firm was founded in 2006 and is headquartered in Portola Valley, California, United States.

## Contacts

5 contacts available for Emergent Medical Partners. Shizune tracks 3 team members at Emergent Medical Partners. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/emergent-medical-partners?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 21 | 54% |
| Medical Device | 18 | 46% |
| Medical | 16 | 41% |
| Biotechnology | 13 | 33% |
| Therapeutics | 6 | 15% |

20 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series C | 8 | 21% |
| Series A | 7 | 18% |
| Series B | 7 | 18% |
| Series D | 5 | 13% |
| Funding Round | 3 | 8% |

10 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 24 | 62% |
| France | 1 | 3% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Allan May | Managing Director | 2 | https://shizune.co/investors/profile/allan-may |
| Bob Brownell | Managing Director | 1 | https://shizune.co/investors/profile/bob-brownell |
| Thomas Fogarty | Co-Founder & Managing Director | 7 | https://shizune.co/investors/profile/thomas-fogarty |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Shape Memory Medical | Shape Memory Medical Inc is a medical device company based in Santa Clara, California, founded to commercialize innovative medical devices based on Shape Memory Polymer (SMP) materials that were developed at Texas A&M University and Lawrence Livermore National Laboratory. The company is dedicated to developing innovative therapeutic solutionsfor peripheral vascular, cardiovascular, and neurovascular markets.Shape Memory Medical's device is the first to introduce an FDA-cleared medical device utilizing shape memory polymer (SMP) technology to a vascular market, enabling physicians to improve patient care. The Shape Memory Medical team has extensive experience with the SMP foam technology and the commercialization of medical devices. | $38M | Series C | Mar 04, 2024 |  |
| Fractyl Health | Fractyl Health develops innovative medical device solutions for the treatment of chronic diseases. The growing product pipeline leverages our minimally invasive procedural therapy, Revita DMR (duodenal mucosal resurfacing), which is designed to rejuvenate the lining of the duodenum and improve patient health. They envision a world with bettersolutions to chronic diseases through the use of less invasive, device-based therapies that will lessen the burden on patients, physicians, and payers.Fractyl Health aims to bring curative therapies to the large populations of patients with metabolic disease. |  | Series F | Aug 15, 2022 |  |
| Standard Bariatrics | Standard Bariatrics is a medical device company that develops and offers surgical instruments for weight-loss surgeries.The company offers Standard Clamp, an instrument that helps surgeons standardize their individual techniques to reduce variation, improve efficiency, and eliminate waste when performing a laparoscopic sleeve gastrectomy.Standard Bariatrics was founded in 2014 and is based in Cincinnati, Ohio. | $35M | Series B | Jun 01, 2021 |  |
| Fractyl Health | Fractyl Health develops innovative medical device solutions for the treatment of chronic diseases. The growing product pipeline leverages our minimally invasive procedural therapy, Revita DMR (duodenal mucosal resurfacing), which is designed to rejuvenate the lining of the duodenum and improve patient health. They envision a world with bettersolutions to chronic diseases through the use of less invasive, device-based therapies that will lessen the burden on patients, physicians, and payers.Fractyl Health aims to bring curative therapies to the large populations of patients with metabolic disease. | $55M | Series E | Aug 06, 2020 |  |
| Fractyl Health | Fractyl Health develops innovative medical device solutions for the treatment of chronic diseases. The growing product pipeline leverages our minimally invasive procedural therapy, Revita DMR (duodenal mucosal resurfacing), which is designed to rejuvenate the lining of the duodenum and improve patient health. They envision a world with bettersolutions to chronic diseases through the use of less invasive, device-based therapies that will lessen the burden on patients, physicians, and payers.Fractyl Health aims to bring curative therapies to the large populations of patients with metabolic disease. | $55M | Series E | Aug 06, 2020 |  |
| Arterys | Arterys is the market leader and the world's first internet platform for medical imaging. Its objective is to transform healthcare by transforming radiology. The Arterys platform is 100% web-based, AI-powered, and FDA-cleared, unlocking simple clinical solutions. | $28M | Series C | May 29, 2020 |  |
| EBR Systems | EBR Systems, Inc. is an early-stage development venture pursuing novel approaches in cardiac rhythm management. EBR Systems develops devices for the treatment of cardiac arrhythmias. | $30M | Private Equity | Aug 27, 2019 |  |
| Standard Bariatrics | Standard Bariatrics is a medical device company that develops and offers surgical instruments for weight-loss surgeries.The company offers Standard Clamp, an instrument that helps surgeons standardize their individual techniques to reduce variation, improve efficiency, and eliminate waste when performing a laparoscopic sleeve gastrectomy.Standard Bariatrics was founded in 2014 and is based in Cincinnati, Ohio. | $20M | Series A | Apr 18, 2018 |  |
| Fractyl Health | Fractyl Health develops innovative medical device solutions for the treatment of chronic diseases. The growing product pipeline leverages our minimally invasive procedural therapy, Revita DMR (duodenal mucosal resurfacing), which is designed to rejuvenate the lining of the duodenum and improve patient health. They envision a world with bettersolutions to chronic diseases through the use of less invasive, device-based therapies that will lessen the burden on patients, physicians, and payers.Fractyl Health aims to bring curative therapies to the large populations of patients with metabolic disease. | $44M | Series D | Nov 30, 2017 |  |
| Arterys | Arterys is the market leader and the world's first internet platform for medical imaging. Its objective is to transform healthcare by transforming radiology. The Arterys platform is 100% web-based, AI-powered, and FDA-cleared, unlocking simple clinical solutions. | $30M | Series B | Nov 15, 2017 |  |

10 of 39 investments shown.

## Co-investors
- [Morgenthaler Ventures](https://shizune.co/investors/profile/morgenthaler-ventures) — VC Fund, 6 deals together
- [Domain Associates](https://shizune.co/investors/profile/domain-associates) — VC Fund, 5 deals together
- [Split Rock Partners](https://shizune.co/investors/profile/split-rock-partners) — VC Fund, 5 deals together
- [Asset Management Ventures (AMV)](https://shizune.co/investors/profile/asset-management-ventures) — VC Fund, 4 deals together
- [Google Ventures](https://shizune.co/investors/profile/google-ventures) — VC Fund, 4 deals together
- [Mithril Capital Management](https://shizune.co/investors/profile/mithril-capital-management) — VC Fund, 4 deals together

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

### Similar country
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## Featured in investor lists
- [Medical Device Investors in United States](https://shizune.co/investors/medical-device-investors-united-states)
- [Medical Device VC Funds in United States](https://shizune.co/investors/medical-device-vc-funds-united-states)

## FAQ

### What does Emergent Medical Partners invest in?

Emergent Medical Partners invests primarily in Health Care, Medical Device and Medical startups, most often at Series C and Series A stage. Most of the 39 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Emergent Medical Partners?

Public channels for Emergent Medical Partners include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Emergent Medical Partners?

The team at Emergent Medical Partners includes Allan May (Managing Director), Bob Brownell (Managing Director) and Thomas Fogarty (Co-Founder & Managing Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co